Search

everythinglearnresearchcommunity

for

Search:↓

Some vaccines might rarely cause hair loss, more research is needed.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

The baby's rash and hair loss were cured with zinc supplements and better skin care.

The 7-month-old boy has a persistent rash that doesn't improve with typical skin treatments.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

HPV vaccines are generally safe but need further investigation for rare side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The article concludes that different types of hair loss require specific treatments and psychological support is important.